» Articles » PMID: 16988280

Application of Mutated Clostridium Difficile Toxin A for Determination of Glucosyltransferase-dependent Effects

Overview
Journal Infect Immun
Date 2006 Sep 22
PMID 16988280
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Mutation of tryptophan-101 in Clostridium difficile toxin A, a 308-kDa glucosyltransferase, resulted in a 50-fold-reduced cytopathic activity in cell culture experiments. The mutant toxin A was characterized and applied to distinguish between glucosyltransferase-dependent and -independent effects with respect to RhoB up-regulation as a cellular stress response.

Citing Articles

Large Clostridial Toxins: Mechanisms and Roles in Disease.

Orrell K, Melnyk R Microbiol Mol Biol Rev. 2021; 85(3):e0006421.

PMID: 34076506 PMC: 8483668. DOI: 10.1128/MMBR.00064-21.


Clostridium difficile toxin glucosyltransferase domains in complex with a non-hydrolyzable UDP-glucose analogue.

Alvin J, Lacy D J Struct Biol. 2017; 198(3):203-209.

PMID: 28433497 PMC: 5534367. DOI: 10.1016/j.jsb.2017.04.006.


Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.

Secore S, Wang S, Doughtry J, Xie J, Miezeiewski M, Rustandi R PLoS One. 2017; 12(1):e0170640.

PMID: 28125650 PMC: 5268477. DOI: 10.1371/journal.pone.0170640.


Crystal structure of Clostridium difficile toxin A.

Chumbler N, Rutherford S, Zhang Z, Farrow M, Lisher J, Farquhar E Nat Microbiol. 2016; 1:15002.

PMID: 27571750 PMC: 4976693. DOI: 10.1038/nmicrobiol.2015.2.


Recombinant Mucin-Type Fusion Proteins with a Galα1,3Gal Substitution as Clostridium difficile Toxin A Inhibitors.

Cherian R, Jin C, Liu J, Karlsson N, Holgersson J Infect Immun. 2016; 84(10):2842-52.

PMID: 27456831 PMC: 5038087. DOI: 10.1128/IAI.00341-16.


References
1.
Busch C, Hofmann F, Gerhard R, Aktories K . Involvement of a conserved tryptophan residue in the UDP-glucose binding of large clostridial cytotoxin glycosyltransferases. J Biol Chem. 2000; 275(18):13228-34. DOI: 10.1074/jbc.275.18.13228. View

2.
Genth H, Huelsenbeck J, Hartmann B, Hofmann F, Just I, Gerhard R . Cellular stability of Rho-GTPases glucosylated by Clostridium difficile toxin B. FEBS Lett. 2006; 580(14):3565-9. DOI: 10.1016/j.febslet.2006.04.100. View

3.
Qadan M, Ramsey M, Daniel J, Spyres L, Safiejko-Mroczka B, Ortiz-Leduc W . Clostridium difficile toxin B activates dual caspase-dependent and caspase-independent apoptosis in intoxicated cells. Cell Microbiol. 2002; 4(7):425-34. DOI: 10.1046/j.1462-5822.2002.00201.x. View

4.
Bhattacharyya S, Kerzmann A, Feig A . Fluorescent analogs of UDP-glucose and their use in characterizing substrate binding by toxin A from Clostridium difficile. Eur J Biochem. 2002; 269(14):3425-32. DOI: 10.1046/j.1432-1033.2002.03013.x. View

5.
Zhao D, Kuhnt-Moore S, Zeng H, Pan A, Wu J, Simeonidis S . Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases. Biochem J. 2002; 368(Pt 2):665-72. PMC: 1222994. DOI: 10.1042/BJ20020950. View